For individuals with autism, cumulative exposure to ACEs is significantly associated with general, physical, and mental health outcomes.
Impaired awareness of hypoglycemia was associated with longer duration of diabetes and daytime hypoglycemia among older adults with type 1 diabetes.
The risk of suicide and homicide is higher at night than might be expected based on the number of people awake at that time.
The FDA has approved Onyda XR (clonidine hydrochloride) extended-release oral suspension for the treatment of attention deficit hyperactivity disorder (ADHD).
Germline variation does not predict the risk for taxane-induced peripheral neuropathy (TIPN) in Black women receiving paclitaxel (once weekly) or docetaxel (every 3 weeks) for early-stage breast ...
The progression of bipolar disorder from major depressive disorder may be more delayed among children and adolescents, relative to adults.
The FDA's Psychopharmacologic Drugs Advisory Committee has voted against the approval of MDMA in combination with psychological intervention for the treatment of PTSD.
Heavy cannabis use is associated with a significantly increased risk for cardiovascular disease (CVD) mortality among women.
A culturally fair dementia screening test for primary care settings, the 5-Cog paradigm, improves dementia diagnoses and care.
Parent-coached exposure therapy outperformed CBT in the effectiveness and efficiency of childhood anxiety disorder treatment.
Child psychiatry access programs may aid primary care providers in increasing patient access to adolescent substance use treatment.
The prevalence of ASD and PTSD among college students in the United States significantly increased from 2017 to 2022.